As regulatory frameworks evolve and clinical innovation accelerates, Canada continues to strengthen its role in healthcare product development.
This year, Xtalks is proud to serve as an official Media Partner for the DIA Canada Annual Meeting, taking place October 26-27, 2026, in Gatineau, Québec.
The meeting will bring together leaders from regulatory agencies, academia, industry and patient communities to explore some of the most pressing issues shaping Canada’s pharmaceutical, medical device and diagnostics sectors.
Offering dedicated tracks in Regulatory, Clinical and Safety and Pharmacovigilance, the meeting provides opportunities to examine both current challenges and future directions across life sciences development.
How Is Canada’s Regulatory Environment Evolving?
Regulatory environments continue to evolve as agencies adapt to advances in science, technology and global collaboration. Organizations are increasingly navigating changing requirements while balancing innovation with quality, efficiency and patient safety.
Sessions within the Regulatory track will explore emerging policies, regulatory convergence and evolving submission expectations. Attendees will gain insight into practical approaches and current thinking shaping Canada’s regulatory environment and its growing role within global regulatory science.
Exploring Clinical Development Trends
Clinical research is becoming increasingly complex as decentralized models, digital technologies and new approaches to patient engagement continue to transform study design and execution.
The Clinical track will examine current trends influencing clinical development and operations, highlighting emerging practices and real-world examples that may help organizations improve execution and adapt to changing expectations.
Advancing Product Safety Through Collaboration and Innovation
As data sources expand and technologies evolve, safety and pharmacovigilance practices continue to become increasingly sophisticated. Organizations are exploring how AI and digital tools can support signal detection, safety monitoring and risk management throughout the product lifecycle.
The Safety and Pharmacovigilance track will bring together stakeholders from industry and health authorities to discuss emerging trends, evolving practices and opportunities to strengthen safety strategies across healthcare products.
Building Connections Across Canada’s Life Sciences Ecosystem
A recurring theme across the meeting is collaboration. Bringing together regulators, industry leaders, patient representatives and academic experts creates opportunities for shared learning and discussion around common challenges.
Through plenary sessions, educational tracks and networking opportunities, attendees will have the chance to exchange perspectives and strengthen connections across Canada’s life sciences ecosystem.
A Meeting for Cross-Functional Life Sciences Professionals
Professionals across regulatory affairs, clinical research, safety, medical affairs and life sciences R&D continue to face increasingly interconnected challenges that require broader perspectives and cross-functional collaboration.
The DIA Canada Annual Meeting offers an opportunity to gain practical insights, hear diverse viewpoints and participate in discussions shaping the future of healthcare product development in Canada.
Register for the meeting and join peers and industry leaders exploring the next phase of regulatory, clinical and safety innovation.
Join or login to leave a comment
JOIN LOGIN